Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

NCT00027729 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: etaracizumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]